J&J MedTech unveiled its long-awaited Ottava with FDA de novo authorization for the first table-integrated soft-tissue ...

Johnson & Johnson announced today that it received FDA de novo authorization for its Ottava surgical robot system.

While Johnson & Johnson will go head to head with Intuitive in the U.S., analysts questioned whether its robotic surgery ...

While not disclosing a specific launch timeframe, with de novo clearance in hand, J&J initially plans to launch Ottava with ...

Nearly six years after unveiling its Ottava robotics platform, Johnson & Johnson (NYSE:JNJ) has finally cleared a major ...

Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the ...

J&J received FDA authorization for OTTAVA robotic surgical system, enabling commercial launch for surgery procedures in the US. Read more.

The U.S. Food and Drug Administration (FDA) has granted De Novo authorization for Johnson & Johnson’s OTTAVA™ Robotic ...